Annotations: 3OE3

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
F	Gal-bind_lectin	e3oe3F1	A: alpha arrays	X: Alpha-beta plaits	H: Phage tail protein-like	T: Transmembrane protein 14A	F: Gal-bind_lectin	ECOD (v295.2)
E	Gal-bind_lectin	e3oe3E1	A: alpha arrays	X: Alpha-beta plaits	H: Phage tail protein-like	T: Transmembrane protein 14A	F: Gal-bind_lectin	ECOD (v295.2)
D	Gal-bind_lectin	e3oe3D1	A: alpha arrays	X: Alpha-beta plaits	H: Phage tail protein-like	T: Transmembrane protein 14A	F: Gal-bind_lectin	ECOD (v295.2)
C	Gal-bind_lectin	e3oe3C1	A: alpha arrays	X: Alpha-beta plaits	H: Phage tail protein-like	T: Transmembrane protein 14A	F: Gal-bind_lectin	ECOD (v295.2)
B	Gal-bind_lectin	e3oe3B1	A: alpha arrays	X: Alpha-beta plaits	H: Phage tail protein-like	T: Transmembrane protein 14A	F: Gal-bind_lectin	ECOD (v295.2)
A		e3oe3A1	A: alpha arrays	X: Acyl-CoA binding protein-like	H: Macro domain-like	T: Macro domain-like	F:	ECOD (v295.2)

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
F	2.40.128.200	Mainly Beta	Beta Barrel	Lipocalin	C-type lysozyme inhibitor	CATH (4.3.0)
E	2.40.128.200	Mainly Beta	Beta Barrel	Lipocalin	C-type lysozyme inhibitor	CATH (4.3.0)
D	2.40.128.200	Mainly Beta	Beta Barrel	Lipocalin	C-type lysozyme inhibitor	CATH (4.3.0)
C	2.40.128.200	Mainly Beta	Beta Barrel	Lipocalin	C-type lysozyme inhibitor	CATH (4.3.0)
B	2.40.128.200	Mainly Beta	Beta Barrel	Lipocalin	C-type lysozyme inhibitor	CATH (4.3.0)
A	2.40.128.200	Mainly Beta	Beta Barrel	Lipocalin	C-type lysozyme inhibitor	CATH (4.3.0)

Chains	Accession	Name	Description	Comments	Source
A, B, C, D, E A, B, C, D, E, F	PF09864	Membrane-bound lysozyme-inhibitor of c-type lysozyme (MliC)	Membrane-bound lysozyme-inhibitor of c-type lysozyme	Lysozymes are ancient and important components of the innate immune system of animals that hydrolyse peptidoglycan, the major bacterial cell wall polymer. Various mechanisms have evolved by which bacteria can evade this bactericidal enzyme, one being ...	Lysozymes are ancient and important components of the innate immune system of animals that hydrolyse peptidoglycan, the major bacterial cell wall polymer. Various mechanisms have evolved by which bacteria can evade this bactericidal enzyme, one being the production of lysozyme inhibitors. MliC (membrane bound lysozyme inhibitor of c-type lysozyme) of E. coli and Pseudomonas aeruginosa, possess lysozyme inhibitory activity and confer increased lysozyme tolerance upon expression in E. coli [1]. Structural analyses show that the invariant loop of MliC plays a crucial role in the inhibition of the lysozyme by its insertion into the active site cleft of the lysozyme, where the loop forms hydrogen and ionic bonds with the catalytic residues [2].	Domain

Chains	Accession	Name	Type
A, B, C, D, E A, B, C, D, E, F	IPR036328	C-type lysozyme inhibitor superfamily	Homologous Superfamily
A, B, C, D, E A, B, C, D, E, F	IPR018660	C-type lysozyme inhibitor	Domain

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

3OE3 | pdb_00003oe3